Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia

Archives of General Psychiatry

Volumn 54, Issue 6, 1997, Pages 559-566

  Gabriel, Steven M ^a,b   Haroutunian, Vahram ^a,b,d   Powchik, Peter ^a,b   Honer, William G ^c   Davidson, Michael ^a,b   Davies, Peter ^b   Davis, Kenneth L ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; MONOCLONAL ANTIBODY; NEUROLEPTIC AGENT; SYNAPTOPHYSIN; SYNTAXIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; BRAIN SYNAPTOSOME; CINGULATE GYRUS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PROTEIN ANALYSIS; SCHIZOPHRENIA;

EID: 0030973411     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.1997.01830180077010     Document Type: Article

References (51)

1. Carpenter WT Jr, Buchanan RW, Kirkpatrick B, Tamminga C, Wood F. Strong inference, theory testing, and the neuroanatomy of schizophrenia. Arch Gen Psychiatry. 1993;50:825-831.
2. Weinberger DR. Neurodevelopmental prespectives in schizophrenia. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven Press; 1995:1171-1184.
3. Kutay FZ, Pogun S, Hariri NI, Peker G, Erlacin S. Free amino acid level determinations in normal and schizophrenic brain. Prog Neuropsychopharmacol Biol Psychiatry. 1989;13:119-126.
4. Reynolds GP, Czudek C, Andrews HB. Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia. Biol Psychiatry. 1990; 27:1038-1044.
5. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE Jr, Jones EG. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry. 1995; 52:258-266; discussion 267-278.
6. A receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci. 1992;12:924-929.
7. Benes FM, Sorensen I, Vincent SL, Bird ED, Sathi M. Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain. Cereb Cortex. 1992;2:503-512.
8. A receptor complex during aging, as assessed in 3- and 24-month-old rat cerebral cortex. Eur J Pharmacol. 1993;246:81-87.
9. Wyatt RJ, Karoum F, Casanova MF. Decreased DOPAC in the anterior cingulate cortex of individuals with schizophrenia. Biol Psychiatry. 1995;38:4-12.
10. Sollner T, Whiteheart SW, Brunner M, Erdjument-Bromage H, Geromanos S, Tempst P, Rothman JE. SNAP receptors implicated in vesicle targeting and fusion. Nature. 1993;362:318-324.
11. 2+-dependent manner. Trends Neurosci. 1995;18:177-183.
12. Bajjalieh SM, Scheller RH. The biochemistry of neurotransmitter secretion. J Biol Chem. 1995;270:1971-1974.
13. Edelmann L, Hanson PI, Chapman ER, Jahn R. Synaptobrevin binding to synaptophysin: a potential mechanism for controlling the exocytotic fusion machine. EMBO J. 1995;14:224-231.
14. Oyler GA, Higgins GA, Hart RA, Battenberg E, Billingsley M, Bloom FE, Wilson MC. The identification of a novel synaptosomal-associated protein, SNAP-25, differentially expressed by neuronal subpopulations. J Cell Biol. 1989;109: 3039-3052.
15. Bennett MK, Calakos N, Scheller RH. Syntaxin: a synaptic protein implicated in docking of synaptic vesicles at presynaptic active zones. Science. 1992;257: 255-259.
16. Jahn R, Schiebler W, Ouimet C, Greengard P. A 38,000-dalton membrane protein (p38) present in synaptic vesicles. Proc Natl Acad Sci U S A. 1985;82: 4137-4141.
17. Oyler GA, Polli JW, Wilson MC, Billingsley ML. Developmental expression of the 25-kDa synaptosomal-associated protein (SNAP-25) in rat brain. Proc Natl Acad Sci U S A. 1991;88:5247-5251.
18. Osen-Sand A, Catsicas M, Staple JK, Jones KA, Ayala G, Knowles J, Grenningloh G, Catsicas S. Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivo. Nature. 1993;364:445-448.
19. Fletcher TL, Cameron P, De Camilli P, Banker G. The distribution of synapsin I and synaptophysin in hippocampal neurons developing in culture. J Neurosci. 1991;11:1617-1626.
20. Leclerc N, Beesley PW, Brown I, Colonnier M, Gurd JW, Paladino T, Hawkes R. Synaptophysin expression during synaptogenesis in the rat cerebellar cortex. J Comp Neurol. 1989;280:197-212.
21. Ferreira A, Kosik KS, Greengard P, Han HQ. Aberrant neurites and synaptic vesicle protein deficiency in synapsin II-depleted neurons. Science. 1994;264: 977-979.
22. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991; 30:572-580.
23. Honer WG, Kaufmann CA, Kleinman JE, Casanova MF, Davies P. Monoclonal antibodies to study the brain in schizophrenia. Brain Res. 1989;500:379-383.
24. Honer WG, Kaufmann CA, Davies P. Characterization of a synaptic antigen of interest in neuropsychiatric illness. Biol Psychiatry. 1992;31:147-158.
25. Honer WG, Hu L, Davies P. Human synaptic proteins with a heterogeneous distribution in cerebellum and visual cortex. Brain Res. 1993;609:9-20.
26. Honer WG, Falkai P, Young C, Wang T, Xie J, Bonner J, Hu L, Boulianne GL, Lu Z, Trimble WS. Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia. 1997. In press.
27. Purohit DP, Davidson M, Perl DP, Powchik P, Haroutunian V, Bierer LM, McCrystal J, Losonczy M, Davis KL. Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study. Biol Psychiatry. 1993;33: 255-260.
28. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol. 1985;42: 1097-1105.
29. Mirra SS, Heyman A, McKeel D, Suni SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L. The consortium to establish a registry for Alzheimer's disease (CERAD), part II: standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41:479-486.
30. Gabriel SM, Bierer LM, Harotunian V, Purohit DP, Perl DP, Davis KL. Widespread deficits in somatostatin but not neuropeptide Y concentrations in Alzheimer's disease cerebral cortex. Neurosci Lett. 1993;155:116-120.
31. Gabriel SM, Davidson M, Haroutunian V, Powchik P, Bierer LM, Purohit DP, Perl DP, Davis KL. Neuropeptide deficits in schizophrenia versus Alzheimer's disease cerebral cortex. Biol Psychiatry. 1996;39:82-91.
32. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566-572.
33. Lowry OH, Rorebrough NJ, Farr AL, Randall RJ. Protein measurement with folin reagent. J Biol Chem. 1951;193:265-272.
34. Aganova EA, Uranova NA. Morphometric analysis of synaptic contacts in the anterior limbic cortex in the endogenous psychoses. Neurosci Behav Physiol. 1992;22:59-65.
35. Browning MD, Dudek EM, Rapier JL, Leonard S, Freedman R. Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics. Biol Psychiatry. 1993;34:529-535.
36. Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry. 1991;48:996-1001.
37. Casanova MF, Stevens JR, Kleinman JE. The neuropathology of schizophrenia: old and new findings. In: Lindenmayer JP, Kay SR, eds. New Biological Vistas in Schizophrenia. New York, NY: Brunner-Mazel; 1992:82-109.
38. Arnold SE, Franz BR, Moberg PJ, Martinoli M, Gur RE, Trojanowski JQ. Molecular markers of neural injury and neurodegeneration in elderly patients with schizophrenia. Presented at the American College of Neuropsychopharmacology; December 11-15, 1995; San Juan, Puerto Rico.
39. Meshul CK, Janowsky A, Casey DE, Stallbaumer RK, Taylor B. Effect of haloperidol and clozapine on the density of perforated synapses in caudate, nucleus accumbens, and medial prefrontal cortex. Psychopharmacology (Berl). 1992; 106:45-52.
40. Uranova NA, Orlovskaya DD, Apel K, Klintsova AJ, Haselhorst U, Schenk H. Morphometric study of synaptic patterns in the rat caudate nucleus and hippocampus under haloperidol treatment. Synapse. 1991;7:253-259.
41. Meshul CK, Casey DE. Regional, reversible ultrastructural changes in rat brain with chronic neuroleptic treatment. Brain Res. 1989;489:338-346.
42. Roberts RC, Gaither LA, Gao XM, Kashyap SM, Tamminga CA. Ultrastructural correlates of haloperidol-induced oral dyskinesias in rat striatum. Synapse. 1995; 20:234-243.
43. Greenough WT, Anderson BJ. Cerebellar synaptic plasticity: relation to learning versus neural activity. Ann N Y Acad Sci. 1991;627:231-247.
44. Masliah E, Terry RD, Alford M, DeTeresa R, Hansen LA. Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease. Am J Pathol. 1991;138:235-246.
45. Hamos JE, DeGennaro LJ, Drachman DA. Synaptic loss in Alzheimer's disease and other dementias. Neurology. 1989;39:355-361.
46. Stevens JR. Abnormal reinnervation as a basis for schizophrenia: a hypothesis. Arch Gen Psychiatry. 1992;49:238-243.
47. Siegel BV Jr, Buchsbaum MS, Bunney WE Jr, Gottschalk LA, Haier RJ, Lohr JB, Lottenberg S, Najafi A, Nuechterlein KH, Potkin SG, Wu JC. Cortical-striatal -thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. Am J Psychiatry. 1993;150:1325-1336.
48. Devinsky O, Morrell MJ, Vogt BA. Contributions of the anterior cingulate cortex to behavior. Brain. 1995;118:279-306.
49. Manberg PJ, Nemeroff CB, Bissette G, Widerlov E, Youngblood WW, Kizer JS, Prange AJ Jr. Neuropeptides in CSF and postmortem brain tissue of normal controls, schizophrenics and Huntington's choreics. Prog Neuropsychopharmacol Biol Psychiatry. 1985;9:97-108.
50. Roberts GW, Ferrier IN, Lee Y, Crow TJ, Johnstone EC, Owens DG, Bacarese-Hamilton AJ, McGregor G, O'Shaughnessey D, Polak JM, et al. Peptides, the limbic lobe and schizophrenia. Brain Res. 1983;288:199-211.
51. Roth BL, Meltzer HY. The role of serotonin in schizophrenia. In: Bloom FE, Kupfer DJ, eds. Psychopharamacology: The Fourth Generation of Progress. New York, NY: Raven Press; 1995:1215-1227.